Acquired pure red cell aplasia: updated review of treatment
about
Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significanceA case of pure red cell aplasia and immune thrombocytopenia complicating systemic lupus erythematosus: response to rituximab and cyclophosphamide.Alemtuzumab plus cyclosporine treatment of the autoimmune hemolytic anemia in an adult bowel transplant.A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.Recurrent severe anaemia: a rare presentation of parvovirus b19 infection.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Acquired pure red cell aplasia in a patient of rheumatoid arthritis.STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemiaAnemia of Central Origin.Dapsone-induced pure red cell aplasia and cholestatic jaundice: A new experience for diagnosis and managementPure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A.Immunomodulatory effects of intravenous immunoglobulins (IVIGs) in HIV-1 disease: a systematic review.Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.Corticosteroid treatment of pure red cell aplasia in a patient with hepatitis A.Overlooked non-motor symptoms in myasthenia gravis.Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab).Pure red cell aplasia and associated thymoma.Carbamazepine-induced Red Blood Cell Aplasia: A Case Report.Post renal transplant pure red cell aplasia-is tacrolimus a culprit?Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia.Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.Pure red cell aplasia in a three-months-old infant possibly secondary to cytomegalo virus infection.Acquired Pure Red Cell Aplasia caused by Parvovirus B19 Infection following a Renal Transplant.Successful treatment of a hemodialyzed patient with pure red cell aplasia associated with epoetin beta pegol therapy with cyclosporine.Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis CPrimary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab.Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report.Treatment of pure red cell aplasia associated with multiple myeloma with biclonal gammopathy using cyclosporine A: a case report.Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone.Pure red cell aplasia associated with cytomegalovirus and Epstein-Barr virus infection in seven cases of Chinese children.Effective treatment of Waldenström macroglobulinemia associated pure red cell aplasia with standard antilymphomatous chemotherapy.Rational management approach to pure red cell aplasia.Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant.Autoimmune Lymphoproliferative Syndrome with Red Cell Aplasia.Pure red cell aplasia due to anti-erythropoietin antibodies or isoniazid? A case report from a 94-year-old man.Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA).Pure red cell aplasia complicating chronic lymphocytic leukemia: rapid response to high-dose methylprednisolone and rituximab.The pharmacokinetic analysis of cyclosporine is essential for the management of refractory pure red cell aplasia.Clinical use of cyclosporine as an adjunctive therapy in the management of feline idiopathic pure red cell aplasia.
P2860
Q26743454-E3AEA6D2-E00B-420A-B6B8-790216518CABQ33397611-BAC16C8D-911A-4882-A58A-CD5E06E79293Q33417439-53EFC251-EE08-4693-82C9-CE81C5ABEEF3Q33439333-A22FF140-505E-431D-9AF2-0B033B704151Q33783400-82232652-7D48-4F31-AF7E-26B5DA8F312AQ34122035-96E1B24C-8E1B-4FB5-85A7-722235219336Q34316187-637F64A3-6E8A-40B5-9920-DC43BDBA1692Q35051957-83EAA8D5-CE17-48AF-B976-04ED4D4F5DB3Q36784115-618DD943-6662-4468-838F-2C35F331991CQ37137765-31DDCD64-42B4-4585-B29D-5FA066EEAA5CQ37558805-F0BA9AA6-6B68-4429-BC81-2C14DC4C612CQ37822450-E36A6944-13D7-441F-AB2B-FD498416ED68Q37843939-FDD635A0-175D-4F5C-A683-273241B7CCA5Q38012974-80E814B4-7CD9-4C1C-8980-6F2117AD8E7AQ38061891-C7A8A7EF-691F-422B-9DD0-1F43EC168780Q38065877-656AA8DA-333A-4E1A-9240-ADF6BBEE252CQ38678564-7DB3C1E2-6345-4613-A816-476707308822Q38757124-1179C860-71A6-4180-BDD6-5F788090FC6BQ38914693-1D41A843-F675-4C4D-B9C9-23D6A852CB4FQ39851542-4D0C4C48-D3C9-431C-B058-BC7FC0DA8C87Q39927825-D5756E63-EC5D-4842-A70A-1E02B49D7367Q41162138-7FE7B806-E035-4E08-8CBA-7CE603FC4DB5Q41693764-C3154C46-6030-42C2-A678-9427C6EE7B75Q41764094-0D5B11DD-1B55-4191-A8B0-600E93C71848Q41821604-FCFFA89E-E767-4E39-85AA-1271149C24A4Q41874865-3212FBC0-68C8-42F8-9568-D3106258595BQ41887039-0E90FACC-0CDE-40BE-8853-495AD785FD74Q42596400-F721C748-1D27-42F1-A113-B46A74A38ABEQ43185136-EB741B00-E7F1-4504-8E4D-53396E0863D3Q44198225-EC17133C-ABA0-4724-ACA8-DA08DD3C67FDQ45353058-C57B3A68-A4A8-428F-92AA-2F15C39E3695Q46137156-412310F8-2232-4BCB-B70F-C61A2E3AF4FBQ47584782-5526DBF5-6521-475A-B493-34A7F061F630Q48098399-D80CA075-F8EA-4D0E-ACE2-2EE0E4CB7377Q50445553-34B63728-666F-4984-847B-7B78E0C0062AQ50453408-915C8067-33B3-4151-B969-8011D6BFF60DQ50462318-4ED0721E-593F-4048-968F-740A8BF3B78AQ50493924-50A0A654-AAA2-4047-A2EA-E5A7A03C432AQ50506212-AC059131-019E-46B5-8408-26C70EACD628Q50526614-3F00E0B1-7E3F-435C-9465-C3F6AE92D216
P2860
Acquired pure red cell aplasia: updated review of treatment
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Acquired pure red cell aplasia: updated review of treatment
@ast
Acquired pure red cell aplasia: updated review of treatment
@en
Acquired pure red cell aplasia: updated review of treatment
@nl
type
label
Acquired pure red cell aplasia: updated review of treatment
@ast
Acquired pure red cell aplasia: updated review of treatment
@en
Acquired pure red cell aplasia: updated review of treatment
@nl
prefLabel
Acquired pure red cell aplasia: updated review of treatment
@ast
Acquired pure red cell aplasia: updated review of treatment
@en
Acquired pure red cell aplasia: updated review of treatment
@nl
P2093
P2860
P921
P3181
P1476
Acquired pure red cell aplasia: updated review of treatment
@en
P2093
Kenichi Sawada
Makoto Hirokawa
Naohito Fujishima
P2860
P304
P3181
P356
10.1111/J.1365-2141.2008.07216.X
P407
P5008
P577
2008-08-01T00:00:00Z